Cargando…
Regulating off-label drug use in India: The arena for concern
Off-label use of drugs is relatively common in medical practice, even if it's often not supported by strong scientific evidence. Off-label use of medicine not only involves physicians and pharmaceutical companies, but regulatory agencies and patients as well. Therapeutic options might get restr...
Autor principal: | Oberoi, Sukhvinder Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504053/ https://www.ncbi.nlm.nih.gov/pubmed/26229747 http://dx.doi.org/10.4103/2229-3485.159935 |
Ejemplares similares
-
Pharmacoeconomics guidelines: The need of hour for India
por: Oberoi, Sukhvinder Singh, et al.
Publicado: (2014) -
Emporiatrics: The growing area of concern
por: Oberoi, Sukhvinder Singh
Publicado: (2014) -
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
por: Peckham, Alyssa M, et al.
Publicado: (2018) -
The Arena
Publicado: (1894) -
Medical tourism-A New Arena
por: Puri, S, et al.
Publicado: (2010)